188 related articles for article (PubMed ID: 23251408)
1. Insulin receptor isoforms A and B as well as insulin receptor substrates-1 and -2 are differentially expressed in prostate cancer.
Heni M; Hennenlotter J; Scharpf M; Lutz SZ; Schwentner C; Todenhöfer T; Schilling D; Kühs U; Gerber V; Machicao F; Staiger H; Häring HU; Stenzl A
PLoS One; 2012; 7(12):e50953. PubMed ID: 23251408
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor overexpression in prostate cancer in type 2 diabetes.
Lutz SZ; Hennenlotter J; Scharpf MO; Sailer C; Fritsche L; Schmid V; Kantartzis K; Wagner R; Lehmann R; Berti L; Peter A; Staiger H; Fritsche A; Fend F; Todenhöfer T; Stenzl A; Häring HU; Heni M
Mol Metab; 2018 Feb; 8():158-166. PubMed ID: 29249638
[TBL] [Abstract][Full Text] [Related]
3. Insulin receptor expression by human prostate cancers.
Cox ME; Gleave ME; Zakikhani M; Bell RH; Piura E; Vickers E; Cunningham M; Larsson O; Fazli L; Pollak M
Prostate; 2009 Jan; 69(1):33-40. PubMed ID: 18785179
[TBL] [Abstract][Full Text] [Related]
4. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.
Schnarr B; Strunz K; Ohsam J; Benner A; Wacker J; Mayer D
Int J Cancer; 2000 Nov; 89(6):506-13. PubMed ID: 11102895
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia.
Sreenivasulu K; Nandeesha H; Dorairajan LN; Rajappa M; Vinayagam V; Cherupanakkal C
Aging Male; 2018 Jun; 21(2):138-144. PubMed ID: 29129118
[TBL] [Abstract][Full Text] [Related]
7. Insulin signaling, androgen receptor and PSMA immunohistochemical analysis by semi-automated tissue microarray in prostate cancer with diabetes (DIAMOND study).
Broggi G; Lo Giudice A; Di Mauro M; Pricoco E; Piombino E; Ferro M; Caltabiano R; Morgia G; Russo GI
Transl Res; 2021 Dec; 238():25-35. PubMed ID: 34314871
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
9. Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.
Singer E; Linehan J; Babilonia G; Imam SA; Smith D; Loera S; Wilson T; Smith S
PLoS One; 2013; 8(6):e60562. PubMed ID: 23762225
[TBL] [Abstract][Full Text] [Related]
10. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease.
Ahearn TU; Peisch S; Pettersson A; Ebot EM; Zhou CK; Graff RE; Sinnott JA; Fazli L; Judson GL; Bismar TA; Rider JR; Gerke T; Chan JM; Fiorentino M; Flavin R; Sesso HD; Finn S; Giovannucci EL; Gleave M; Loda M; Li Z; Pollak M; Mucci LA;
Carcinogenesis; 2018 Dec; 39(12):1431-1437. PubMed ID: 30165429
[TBL] [Abstract][Full Text] [Related]
11. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
[TBL] [Abstract][Full Text] [Related]
12. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.
Cordon-Cardo C; Koff A; Drobnjak M; Capodieci P; Osman I; Millard SS; Gaudin PB; Fazzari M; Zhang ZF; Massague J; Scher HI
J Natl Cancer Inst; 1998 Sep; 90(17):1284-91. PubMed ID: 9731735
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
[TBL] [Abstract][Full Text] [Related]
14. Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia.
Hu XY; Xu YM; Fu Q; Yu JJ; Huang J
Eur J Surg Oncol; 2009 May; 35(5):527-31. PubMed ID: 19004604
[TBL] [Abstract][Full Text] [Related]
15. The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer.
Ibuki N; Ghaffari M; Reuveni H; Pandey M; Fazli L; Azuma H; Gleave ME; Levitzki A; Cox ME
Mol Cancer Ther; 2014 Dec; 13(12):2827-39. PubMed ID: 25267499
[TBL] [Abstract][Full Text] [Related]
16. Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.
Bergström SH; Järemo H; Nilsson M; Adamo HH; Bergh A
Prostate; 2018 Mar; 78(4):257-265. PubMed ID: 29250809
[TBL] [Abstract][Full Text] [Related]
17. miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1.
Meng Y; Hu X; Li S; Zeng X; Qiu L; Wei M; Wang Z; Han J
BMC Cancer; 2020 Oct; 20(1):1028. PubMed ID: 33109107
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of tissue and circulating levels of IMP3 in prostate cancer.
Szarvas T; Tschirdewahn S; Niedworok C; Kramer G; Sevcenco S; Reis H; Shariat SF; Rübben H; vom Dorp F
Int J Cancer; 2014 Oct; 135(7):1596-604. PubMed ID: 24615121
[TBL] [Abstract][Full Text] [Related]
19. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.
Hellawell GO; Turner GD; Davies DR; Poulsom R; Brewster SF; Macaulay VM
Cancer Res; 2002 May; 62(10):2942-50. PubMed ID: 12019176
[TBL] [Abstract][Full Text] [Related]
20. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance].
Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H
Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
